These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 20146152)

  • 1. [Dual diagnosis psychosis and substance use disorders in adolescents--part 1].
    Meister K; Burlon M; Rietschel L; Gouzoulis-Mayfrank E; Bock T; Lambert M
    Fortschr Neurol Psychiatr; 2010 Feb; 78(2):81-9. PubMed ID: 20146152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reasons for increased substance use in psychosis.
    Gregg L; Barrowclough C; Haddock G
    Clin Psychol Rev; 2007 May; 27(4):494-510. PubMed ID: 17240501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual diagnosis: a review of etiological theories.
    Mueser KT; Drake RE; Wallach MA
    Addict Behav; 1998; 23(6):717-34. PubMed ID: 9801712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dual diagnosis in psychiatric inpatients: prevalence and general characteristics].
    Rodríguez-Jiménez R; Aragüés M; Jiménez-Arriero MA; Ponce G; Muñoz A; Bagney A; Hoenicka J; Palomo T
    Invest Clin; 2008 Jun; 49(2):195-205. PubMed ID: 18717266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral interventions for dual-diagnosis patients.
    Goldsmith RJ; Garlapati V
    Psychiatr Clin North Am; 2004 Dec; 27(4):709-25. PubMed ID: 15550289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
    Liraud F; Verdoux H
    Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substance abuse and the management of medication nonadherence in schizophrenia.
    Wilk J; Marcus SC; West J; Countis L; Hall R; Regier DA; Olfson M
    J Nerv Ment Dis; 2006 Jun; 194(6):454-7. PubMed ID: 16772865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of substance use disorder on the clinical presentation of anxiety and depression in an outpatient psychiatric clinic.
    Tsuang D; Cowley D; Ries R; Dunner DL; Roy-Byrne PP
    J Clin Psychiatry; 1995 Dec; 56(12):549-55. PubMed ID: 8530330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychiatric comorbidity in forensic psychiatry.
    Palijan TZ; Muzinić L; Radeljak S
    Psychiatr Danub; 2009 Sep; 21(3):429-36. PubMed ID: 19794370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of age at first substance use and psychiatric comorbidity on the development of substance use disorders.
    Sung M; Erkanli A; Angold A; Costello EJ
    Drug Alcohol Depend; 2004 Sep; 75(3):287-99. PubMed ID: 15283950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of co-occurring substance use on 6 month outcomes for young people seeking mental health treatment.
    Baker KD; Lubman DI; Cosgrave EM; Killackey EJ; Yuen HP; Hides L; Baksheev GN; Buckby JA; Yung AR
    Aust N Z J Psychiatry; 2007 Nov; 41(11):896-902. PubMed ID: 17924242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative study of substance dependence comorbidity in bipolar, schizophrenic and schizoaffective disorders].
    Verdoux H; Mury M; Besançon G; Bourgeois M
    Encephale; 1996; 22(2):95-101. PubMed ID: 8706627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substance use in severe mental illness: self-medication and vulnerability factors.
    Bizzarri JV; Rucci P; Sbrana A; Miniati M; Raimondi F; Ravani L; Massei GJ; Milani F; Milianti M; Massei G; Gonnelli C; Cassano GB
    Psychiatry Res; 2009 Jan; 165(1-2):88-95. PubMed ID: 19054572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comorbid substance use disorder in schizophrenia: a selective overview of neurobiological and cognitive underpinnings.
    Thoma P; Daum I
    Psychiatry Clin Neurosci; 2013 Sep; 67(6):367-83. PubMed ID: 23890122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Addiction and schizophrenia. Nosological, clinical and therapeutic questions. 2. Substance dependence and schizophrenia].
    Soyka M
    Fortschr Neurol Psychiatr; 1994 Jun; 62(6):186-96. PubMed ID: 8050773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Processing of social emotion in patients with schizophrenia and substance use disorder: an fMRI study.
    Potvin S; Mancini-Marie A; Fahim C; Mensour B; Stip E
    Soc Neurosci; 2007; 2(2):106-16. PubMed ID: 18633810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substance use disorders and comorbid mental disorders in first-time admitted patients from a catchment area.
    Langås AM; Malt UF; Opjordsmoen S
    Eur Addict Res; 2012; 18(1):16-25. PubMed ID: 22042311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychiatric comorbidity in illicit drug users: substance-induced versus independent disorders.
    Torrens M; Gilchrist G; Domingo-Salvany A;
    Drug Alcohol Depend; 2011 Jan; 113(2-3):147-56. PubMed ID: 20801586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of comorbidity: major mental illness and problematic substance use.
    Cohen SI
    Aust N Z J Psychiatry; 1999 Aug; 33(4):601. PubMed ID: 10483859
    [No Abstract]   [Full Text] [Related]  

  • 20. Adolescent substance abuse and psychiatric comorbidities.
    Deas D
    J Clin Psychiatry; 2006; 67 Suppl 7():18-23. PubMed ID: 16961420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.